[go: up one dir, main page]

BR9106377A - COMPOSITION AND PROCESS FOR TOPICAL TREATMENT OF INJURED OR NURSING TISSUE - Google Patents

COMPOSITION AND PROCESS FOR TOPICAL TREATMENT OF INJURED OR NURSING TISSUE

Info

Publication number
BR9106377A
BR9106377A BR919106377A BR9106377A BR9106377A BR 9106377 A BR9106377 A BR 9106377A BR 919106377 A BR919106377 A BR 919106377A BR 9106377 A BR9106377 A BR 9106377A BR 9106377 A BR9106377 A BR 9106377A
Authority
BR
Brazil
Prior art keywords
injured
composition
topical treatment
nursing
tissue
Prior art date
Application number
BR919106377A
Other languages
Portuguese (pt)
Inventor
R Martin Emanuele
Robert L Hunter
Original Assignee
Cytrx Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytrx Corp filed Critical Cytrx Corp
Publication of BR9106377A publication Critical patent/BR9106377A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BR919106377A 1990-04-26 1991-04-25 COMPOSITION AND PROCESS FOR TOPICAL TREATMENT OF INJURED OR NURSING TISSUE BR9106377A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51350990A 1990-04-26 1990-04-26
US68703491A 1991-04-22 1991-04-22
PCT/US1991/002912 WO1991016058A1 (en) 1990-04-26 1991-04-25 Composition and method for topical treatment of damaged or diseased tissue

Publications (1)

Publication Number Publication Date
BR9106377A true BR9106377A (en) 1993-04-27

Family

ID=27057898

Family Applications (1)

Application Number Title Priority Date Filing Date
BR919106377A BR9106377A (en) 1990-04-26 1991-04-25 COMPOSITION AND PROCESS FOR TOPICAL TREATMENT OF INJURED OR NURSING TISSUE

Country Status (10)

Country Link
EP (1) EP0526578A4 (en)
JP (1) JPH0776175B2 (en)
CN (1) CN1058341A (en)
AU (1) AU647484B2 (en)
BR (1) BR9106377A (en)
CA (1) CA2081340A1 (en)
IE (1) IE911403A1 (en)
IL (1) IL97976A0 (en)
PT (1) PT97504A (en)
WO (1) WO1991016058A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
US6153193A (en) * 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
US6093391A (en) * 1992-10-08 2000-07-25 Supratek Pharma, Inc. Peptide copolymer compositions
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
US6353055B1 (en) 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
US6221959B1 (en) 1994-11-18 2001-04-24 Supratek Pharma, Inc. Polynucleotide compositions
CA2232527C (en) * 1995-09-19 2008-09-02 Seikagaku Corporation Anti-inflammatory agent
JP2001187740A (en) * 2000-01-05 2001-07-10 Seikagaku Kogyo Co Ltd Vulnerary agent
FR2833268B1 (en) * 2001-12-12 2005-07-08 Fabre Pierre Dermo Cosmetique NOVEL ASSOCIATION CONTAINING POLOXAMER AND CHONDROID SULFURIC ACID AND / OR GLYCOPROTEIN AND USE THEREOF
CN111148749A (en) 2016-08-31 2020-05-12 王子控股株式会社 Production method of acidic xylo-oligosaccharide and acidic xylo-oligosaccharide
JP6225321B1 (en) 2016-08-31 2017-11-08 王子ホールディングス株式会社 Method for producing polysulfate pentosan
JP6281659B1 (en) 2017-02-28 2018-02-21 王子ホールディングス株式会社 Polysulfate pentosan, pharmaceutical composition and anticoagulant
CN110678189A (en) * 2017-05-31 2020-01-10 王子控股株式会社 Moisture-retaining external preparation
EP3683242B1 (en) 2017-09-12 2024-10-30 Oji Holdings Corporation Pentosan polysulfate and method for producing pentosan polysulfate
ES2946281T3 (en) 2017-12-20 2023-07-14 Oji Holdings Corp Pentosan polysulfate and medicine containing pentosan polysulfate
CN111228466B (en) * 2020-02-27 2023-06-27 温州医科大学 Oxygen-containing microbubble hydrogel for treating diabetic foot, preparation method and application thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997458A (en) * 1974-04-12 1976-12-14 Deknatel, Incorporated Method of cleansing contaminated wounds and surgical scrub solutions for same
US4052513A (en) * 1974-12-13 1977-10-04 Plough, Inc. Stable topical anesthetic compositions
IT1212892B (en) * 1983-10-11 1989-11-30 Della Valle Francesco HYALURONIC ACID OBTAINED BY MEANS OF MOLECULAR FILTRATION WITHOUT INFLAMMATORY ACTIVITY AND ITS THERAPEUTIC USE
US4745098A (en) * 1984-02-24 1988-05-17 The Regents Of The University Of California Compositions and method for improving wound healing
US4711780A (en) * 1984-06-11 1987-12-08 Fahim Mostafa S Composition and process for promoting epithelial regeneration
CH662505A5 (en) * 1985-04-30 1987-10-15 Seuref Ag Pharmaceutical composition for protective action vascular.
JPS61253065A (en) * 1985-05-02 1986-11-10 片倉チツカリン株式会社 Composite medical material of chitosan derivative and collagen and its manufacturing method
FR2585575B1 (en) * 1985-08-01 1989-03-03 Pf Medicament PHARMACEUTICAL COMPOSITIONS WITH KERATOLYTIC ACTIVITY IN GEL FORM COMPRISING HYDROALCOHOLIC SALICYLIC ACID
US4760131A (en) * 1986-04-23 1988-07-26 Collagen Corporation Wound-healing composition
CA1294546C (en) * 1986-04-23 1992-01-21 John S. Sundsmo Wound healing composition containing collagen
US4879109A (en) * 1986-05-15 1989-11-07 Emory University Method for treating burns
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor

Also Published As

Publication number Publication date
AU647484B2 (en) 1994-03-24
WO1991016058A1 (en) 1991-10-31
CN1058341A (en) 1992-02-05
AU7869291A (en) 1991-11-11
IE911403A1 (en) 1991-11-06
EP0526578A4 (en) 1993-09-22
EP0526578A1 (en) 1993-02-10
JPH0776175B2 (en) 1995-08-16
JPH05506861A (en) 1993-10-07
CA2081340A1 (en) 1991-10-27
IL97976A0 (en) 1992-06-21
PT97504A (en) 1992-02-28

Similar Documents

Publication Publication Date Title
BR8900357A (en) COMPOSITION AND TISSUE TREATMENT PROCESS AND PROCESS FOR THE PREPARATION OF THESE COMPOSITION
BR8900948A (en) AQUEOUS TISSUE CONDITIONING COMPOSITION AND TISSUE TREATMENT PROCESS
BR9106377A (en) COMPOSITION AND PROCESS FOR TOPICAL TREATMENT OF INJURED OR NURSING TISSUE
FI963696L (en) Gel for the treatment of skin diseases and skin disinfection
PT93791A (en) DEVICE FOR TREATMENT OF SPECIAL MEDICAL WASTE
BR9000990A (en) WATER COMPOSITION TISSUE CONDITIONER AND PROCESS FOR TISSUE TREATMENT
BR8305329A (en) BANDAGE AND PROCESS TO TREAT PAIN AND / OR INFLAMMATION
BR9612204A (en) Compound use of the compound Pharmaceutical composition and process for preparing the compound and for treating pain
BR8300475A (en) COMPOUND, PHARMACEUTICAL COMPOSITION, PROCESS FOR TREATMENT OF VIROTIC INFECTION IN A HOT BLOOD OR COLD BLOOD ANIMAL, AND PROCESS FOR THE PREPARATION OF SUCH COMPOUND
BR9408148A (en) Process for the treatment of compound arrhythmia and pharmaceutical formulation
PT88972A (en) Process for the preparation of a composition useful for treatment of the hair or the skin
DE68916036D1 (en) AGENT FOR TREATMENT AND PROPHYLAXIS OF CORONARY AND CEREBRAL ISCHEMIC DISEASES.
KR920700634A (en) Methods for treating acne or psoriasis skin diseases and compositions used therein
BR8900962A (en) BACTERICIDE COMPOSITION AND TREATMENT PROCESS
BR9506581A (en) Compound pharmaceutical composition use of the process compound for the prophylaxis or treatment of a clinical condition in a manifer for example a human and for the preparation of a compound and intermediate compound
BR9708607A (en) Compound pharmaceutical composition use of a compound process for treating or reducing the risk of inflammatory disease in a patient and for the preparation of a compound and chemical intermediate
BR8801105A (en) COMPOSITIONS FOR SKIN CARE AND METHOD FOR SKIN TREATMENT
BR9105287A (en) COMPOSITION AND PROCESS FOR HAIR TREATMENT
BR9502471A (en) Guanidine compound Process for preparing a guanidine compound Pharmaceutical composition Use of a guanidine compound Method for the prophylactic or therapeutic treatment of diseases and process for preparing a pharmaceutical composition
PT82608A (en) PROCESS FOR THE TREATMENT OF SEEDS AND SEEDS SO TREATED
BR9510015A (en) Compound pharmaceutical composition and process for the treatment of infectious diseases in human or veterinary therapy
IT8868118A0 (en) COMPOSITION AND PROCEDURE FOR THE TREATMENT AND CARE OF HAIR
BR8901135A (en) TISSUE CONDITIONING COMPOSITION AND TISSUE TREATMENT PROCESS
BR9708864A (en) Compound pharmaceutical composition and process for the treatment or prevention of a bacterial infection in a mammalian patient
BR9612234A (en) Compound process for preparing the same use of the compound and processes for treating airway diseases and treatment or prophylaxis of glaucoma

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal